Charme y Miura lanzan el proceso de venta de Indiba valorada en 500 millones
Evercore coordina la venta de la empresa conocida por sus tratamientos de radiofrecuencia, que despierta el apetito de los fondos. Leer
Italian capital risk manager Charme Capital Partners and Spanish Miura Partners have initiated the sale process for Indiba, a Spanish pioneer in RF treatments for aesthetic, beauty, rehabilitation, sports and intimate health, aiming to secure an agreement before year-end, according to market sources. Business bank Evercore is coordinating the operation, which could value the company at around 500 million euros, sources say.
Indiba's business information will be distributed among the market in the coming days, and interested parties must submit non-binding offers by mid-October. Indiba's ebitda, used by athletes like Rafael Nadal and Carlos Sainz, among others, is expected to be around 40 million euros by year-end. The company's annual revenues exceed 100 million euros, with half coming from Asia, particularly China.
Charme, led by Matteo di Montezemolo, holds about 52% of Indiba, Miura has roughly 28%, and Tresmares, a Santander-owned manager, controls over 10%. The founders acquired the company from Magnum Capital in early 2022, and since then, they have nearly doubled its size. When Charme and Miura took control, revenues were around 40 million euros, with an ebitda of 13-15 million euros.
Indiba's impressive growth has already caught the attention of major international venture capital firms, leading to an expected competitive process. The company refinanced approximately 87 million euros of debt in April with a group of financial entities, including Tresmares, Santander, Bank of Ireland, CaixaBank, and Sabadell, as EXPANSIÓN reported on March 6.
Written by urgent.news from Expansion ES's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.